Author:
Biswal Biswa Mohan,Zakaria Ahmad,Ahmad Nik Min
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics 2000. CA Cancer J Clin 50:7–33
2. Trotti A (2000) Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncl Biol Phys 47:1–12
3. Lee DJ, Cosmatos D, Marcial VA et al (1995) Results of an RTOG phase III trial (RTOG 85–27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas . Int J Radiat Oncol Biol Phys 32:567–576
4. Fu KK (1993) RTOG (90–03): A phase III randomized study to compare twice daily hyperfractionation, accelerated fractionation with concomitant boost to standard fractionation radiotherapy for squamous cell carcinoma of the head and neck. Data on file, Radiation Treatment Oncology Group, Philadelphia
5. Horiot K, Le Fur R, N'Guyen T et al (1992) Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25:231–241
Cited by
155 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献